Stefan Traussnigg

Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations

Albert Friedrich Stättermayer, Stefan Traussnigg, Hans‐Peter Dienes et al. · Journal of Hepatology · 2015 · 106 citations

Medicine, Molecular Genetics, Pathology +15

Noninvasive Differentiation of Simple Steatosis and Steatohepatitis by Using Gadoxetic Acid–enhanced MR Imaging in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study

Nina Bastati, Diana Feier, Andreas G. Wibmer et al. · Radiology · 2014 · 88 citations

Medicine, Internal Medicine, Radiology +17

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

Stefan Traussnigg, Jörn M. Schattenberg, Münevver Demir et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 82 citations

Medicine, Pharmacology, Pharmacotherapy +10

Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency

Maria Luger, Renate Kruschitz, Christian Kienbacher et al. · Obesity Surgery · 2016 · 57 citations · Full text

Medicine, Endocrinology, Clinical Nutrition +16

Ultra‐high‐field magnetic resonance spectroscopy in non‐alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non‐alcoholic steatohepatitis and advanced fibrosis

Stefan Traussnigg, Christian Kienbacher, Martin Gajdošík et al. · Liver International · 2017 · 47 citations · Full text

Life Sciences, Biochemistry, Lipid Biochemistry +16